An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway

被引:1328
作者
Kliewer, SA [1 ]
Moore, JT
Wade, L
Staudinger, JL
Watson, MA
Jones, SA
McKee, DD
Oliver, BB
Willson, TM
Zetterström, RH
Perlmann, T
Lehmann, JM
机构
[1] Glaxo Wellcome Res & Dev Ltd, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA
[2] Glaxo Wellcome Res & Dev Ltd, Dept Mol Sci, Res Triangle Pk, NC 27709 USA
[3] Glaxo Wellcome Res & Dev Ltd, Dept Med Chem, Res Triangle Pk, NC 27709 USA
[4] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden
[5] Ludwig Inst Canc Res, Stockholm Branch, S-17177 Stockholm, Sweden
关键词
D O I
10.1016/S0092-8674(00)80900-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Steroid hormones exert profound effects on differentiation, development, and homeostasis in higher eukaryotes through interactions with nuclear receptors. We describe a novel orphan nuclear receptor, termed the pregnane X receptor (PXR), that is activated by naturally occurring steroids such as pregnenolone and progesterone, and synthetic glucocorticoids and antiglucocorticoids. PXR exists as two isoforms, PXR.1 and PXR.2, that are differentially activated by steroids. Notably, PXR.1 is efficaciously activated by pregnenolone 16 alpha-carbonitrile, a glucocorticoid receptor antagonist that induces the expression of the CYP3A family of steroid hydroxylases and modulates sterol and bile acid biosynthesis in vivo. Our results provide evidence for the existence of a novel steroid hormone signaling pathway with potential implications in the regulation of steroid hormone and sterol homeostasis.
引用
收藏
页码:73 / 82
页数:10
相关论文
共 57 条